Research summary
Research HubSermorelin
Clinical — 10 studies
Sermorelin is a synthetic analogue of growth hormone–releasing hormone studied for stimulating endogenous GH production.
Being studied for
- GH secretion in aging research
- Pituitary function studies
Published Research
Evidence profile
Preclinical, with limited uncontrolled human reports
10 cited publications
Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.
Additional indexed literature (10)
- Clinical · Mechanistic studyA potentially effective drug for patients with recurrent glioma: sermorelin
Chang Y et al. · Annals of translational medicine · 2021 · PMID 33842627
- Preclinical · Mechanistic studyCationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples
Cristea CD et al. · Analytical biochemistry · 2023 · PMID 37806509
- Preclinical · Mechanistic studyOnline large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis
Otin J et al. · Electrophoresis · 2023 · PMID 36787346
- Preclinical · Mechanistic studyIn-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides
González-López NM et al. · Biomedical chromatography : BMC · 2023 · PMID 37688464
- Preclinical · Mechanistic studyAn antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS
Coppieters G et al. · Journal of pharmaceutical and biomedical analysis · 2022 · PMID 35298973
- Preclinical · Mechanistic studyAdvances in the detection of growth hormone releasing hormone synthetic analogs
Memdouh S et al. · Drug testing and analysis · 2021 · PMID 34665524
- Preclinical · Mechanistic studyInteractions of GRF(1-29)NH2 with plasma proteins and their effects on the release of the peptide from a PLAGA matrix
Mariette B et al. · Journal of controlled release : official journal of the Controlled Release Society · 2005 · PMID 15987661
- Preclinical · Mechanistic studyA comparison of the biological activities of authentic rat GRF(1-43)OH with the analogue rat GRF(1-29)NH2
Kraicer J et al. · Canadian journal of physiology and pharmacology · 1991 · PMID 1829020
- Preclinical · Mechanistic studyComparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas
Robberecht P et al. · Peptides · 1986 · PMID 3018703
- Preclinical · Mechanistic studySuper-active analogs of growth hormone-releasing factor (1-29)-amide
Lance VA et al. · Biochemical and biophysical research communications · 1984 · PMID 6231028
Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.
Notice
All information on this page is provided strictly for laboratory research and educational purposes only.